Related Experiment Videos

p202 levels are negatively regulated by serum growth factors

Y Geng1, S D'Souza, H Xin

  • 1Department of Radiation Oncology, Stritch School of Medicine, Loyola University Medical Center, Maywood, Illinois 60153, USA.

Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|September 28, 2000
PubMed

Insights

Reduced serum conditions increase fibroblast p202 levels, correlating with cell cycle arrest. JunD/AP-1 transcription factor up-regulates p202, potentially regulating apoptosis.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • p202 is an IFN-inducible phosphoprotein that inhibits cell proliferation.
  • Reduced p202 levels in fibroblasts under low serum conditions increase apoptosis susceptibility.

Purpose of the Study:

  • To investigate the functional role of p202 in cell growth regulation.
  • To determine if serum growth factors affect p202 levels.

Main Methods:

  • Fibroblast cultures under reduced serum conditions.
  • Analysis of p202 mRNA and protein levels.
  • Treatment with growth factors (PDGF, bFGF, TGF-β1).
  • JunD/AP-1 expression and activity assays.
  • Reporter gene assays (luciferase).

Main Results:

  • Reduced serum increased p202 levels at both mRNA and protein levels, correlating with G1 cell cycle arrest.
  • Growth factors abrogated the serum-deprivation-induced increase in p202.
  • Increased p202 levels were associated with elevated JunD/AP-1 levels.
  • JunD/AP-1 directly bound to the p202 gene's regulatory region, enhancing its transcription.

Conclusions:

  • In fibroblasts, reduced serum conditions lead to increased JunD/AP-1 levels.
  • JunD/AP-1 contributes to the transcriptional up-regulation of p202.
  • Elevated p202 levels may play a role in regulating apoptosis under low serum conditions.

Related Concept Videos